K. Quirk et al., [H-3] L-655,708, A NOVEL LIGAND SELECTIVE FOR THE BENZODIAZEPINE SITEOF GABA(A) RECEPTORS WHICH CONTAIN THE ALPHA-5 SUBUNIT, Neuropharmacology, 35(9-10), 1996, pp. 1331-1335
A compound (L-655,708) has been identified which has at least 50-fold
selectivity for the benzodiazepine site on GABA(A) receptors containin
g an alpha 5 subunit over those containing an alpha 1, alpha 2, alpha
3 or alpha 6 subunit in combination with beta 3 and gamma 2. The compo
und was radiolabelled with tritium and investigated as a novel radioli
gand which recognizes the benzodiazepine site of GABA(A) receptors whi
ch contain the alpha 5 subunit. [H-3]L-655,708 labels one saturable an
d specific population of binding sites in rat hippocampus with a K-d o
f 2.4 +/- 0.7 nM and a B-max of 256 +/- 42 fmol/mg protein. The pharma
cology of the binding site labelled was consistent with that of recept
ors present in cells transfected with alpha 5, beta 2 and gamma 2 and
with receptors immunoprecipitated from rat brain with an alpha 5-selec
tive antiserum. It is concluded that [H-3]L-655,708 is the first radio
ligand to date which is selective for any BZ2 subtype of the GABA(A) r
eceptor and should provide a valuable tool for elucidating the structu
re and function of the alpha 5-containing GABA(A) receptor subtype. Co
pyright (C) 1996 Elsevier Science Ltd.